Cargando…

StudyU: A Platform for Designing and Conducting Innovative Digital N-of-1 Trials

N-of-1 trials are the gold standard study design to evaluate individual treatment effects and derive personalized treatment strategies. Digital tools have the potential to initiate a new era of N-of-1 trials in terms of scale and scope, but fully functional platforms are not yet available. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Konigorski, Stefan, Wernicke, Sarah, Slosarek, Tamara, Zenner, Alexander M, Strelow, Nils, Ruether, Darius F, Henschel, Florian, Manaswini, Manisha, Pottbäcker, Fabian, Edelman, Jonathan A, Owoyele, Babajide, Danieletto, Matteo, Golden, Eddye, Zweig, Micol, Nadkarni, Girish N, Böttinger, Erwin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297132/
https://www.ncbi.nlm.nih.gov/pubmed/35787512
http://dx.doi.org/10.2196/35884
_version_ 1784750412417466368
author Konigorski, Stefan
Wernicke, Sarah
Slosarek, Tamara
Zenner, Alexander M
Strelow, Nils
Ruether, Darius F
Henschel, Florian
Manaswini, Manisha
Pottbäcker, Fabian
Edelman, Jonathan A
Owoyele, Babajide
Danieletto, Matteo
Golden, Eddye
Zweig, Micol
Nadkarni, Girish N
Böttinger, Erwin
author_facet Konigorski, Stefan
Wernicke, Sarah
Slosarek, Tamara
Zenner, Alexander M
Strelow, Nils
Ruether, Darius F
Henschel, Florian
Manaswini, Manisha
Pottbäcker, Fabian
Edelman, Jonathan A
Owoyele, Babajide
Danieletto, Matteo
Golden, Eddye
Zweig, Micol
Nadkarni, Girish N
Böttinger, Erwin
author_sort Konigorski, Stefan
collection PubMed
description N-of-1 trials are the gold standard study design to evaluate individual treatment effects and derive personalized treatment strategies. Digital tools have the potential to initiate a new era of N-of-1 trials in terms of scale and scope, but fully functional platforms are not yet available. Here, we present the open source StudyU platform, which includes the StudyU Designer and StudyU app. With the StudyU Designer, scientists are given a collaborative web application to digitally specify, publish, and conduct N-of-1 trials. The StudyU app is a smartphone app with innovative user-centric elements for participants to partake in trials published through the StudyU Designer to assess the effects of different interventions on their health. Thereby, the StudyU platform allows clinicians and researchers worldwide to easily design and conduct digital N-of-1 trials in a safe manner. We envision that StudyU can change the landscape of personalized treatments both for patients and healthy individuals, democratize and personalize evidence generation for self-optimization and medicine, and can be integrated in clinical practice.
format Online
Article
Text
id pubmed-9297132
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-92971322022-07-21 StudyU: A Platform for Designing and Conducting Innovative Digital N-of-1 Trials Konigorski, Stefan Wernicke, Sarah Slosarek, Tamara Zenner, Alexander M Strelow, Nils Ruether, Darius F Henschel, Florian Manaswini, Manisha Pottbäcker, Fabian Edelman, Jonathan A Owoyele, Babajide Danieletto, Matteo Golden, Eddye Zweig, Micol Nadkarni, Girish N Böttinger, Erwin J Med Internet Res Viewpoint N-of-1 trials are the gold standard study design to evaluate individual treatment effects and derive personalized treatment strategies. Digital tools have the potential to initiate a new era of N-of-1 trials in terms of scale and scope, but fully functional platforms are not yet available. Here, we present the open source StudyU platform, which includes the StudyU Designer and StudyU app. With the StudyU Designer, scientists are given a collaborative web application to digitally specify, publish, and conduct N-of-1 trials. The StudyU app is a smartphone app with innovative user-centric elements for participants to partake in trials published through the StudyU Designer to assess the effects of different interventions on their health. Thereby, the StudyU platform allows clinicians and researchers worldwide to easily design and conduct digital N-of-1 trials in a safe manner. We envision that StudyU can change the landscape of personalized treatments both for patients and healthy individuals, democratize and personalize evidence generation for self-optimization and medicine, and can be integrated in clinical practice. JMIR Publications 2022-07-05 /pmc/articles/PMC9297132/ /pubmed/35787512 http://dx.doi.org/10.2196/35884 Text en ©Stefan Konigorski, Sarah Wernicke, Tamara Slosarek, Alexander M Zenner, Nils Strelow, Darius F Ruether, Florian Henschel, Manisha Manaswini, Fabian Pottbäcker, Jonathan A Edelman, Babajide Owoyele, Matteo Danieletto, Eddye Golden, Micol Zweig, Girish N Nadkarni, Erwin Böttinger. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 05.07.2022. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on https://www.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Viewpoint
Konigorski, Stefan
Wernicke, Sarah
Slosarek, Tamara
Zenner, Alexander M
Strelow, Nils
Ruether, Darius F
Henschel, Florian
Manaswini, Manisha
Pottbäcker, Fabian
Edelman, Jonathan A
Owoyele, Babajide
Danieletto, Matteo
Golden, Eddye
Zweig, Micol
Nadkarni, Girish N
Böttinger, Erwin
StudyU: A Platform for Designing and Conducting Innovative Digital N-of-1 Trials
title StudyU: A Platform for Designing and Conducting Innovative Digital N-of-1 Trials
title_full StudyU: A Platform for Designing and Conducting Innovative Digital N-of-1 Trials
title_fullStr StudyU: A Platform for Designing and Conducting Innovative Digital N-of-1 Trials
title_full_unstemmed StudyU: A Platform for Designing and Conducting Innovative Digital N-of-1 Trials
title_short StudyU: A Platform for Designing and Conducting Innovative Digital N-of-1 Trials
title_sort studyu: a platform for designing and conducting innovative digital n-of-1 trials
topic Viewpoint
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297132/
https://www.ncbi.nlm.nih.gov/pubmed/35787512
http://dx.doi.org/10.2196/35884
work_keys_str_mv AT konigorskistefan studyuaplatformfordesigningandconductinginnovativedigitalnof1trials
AT wernickesarah studyuaplatformfordesigningandconductinginnovativedigitalnof1trials
AT slosarektamara studyuaplatformfordesigningandconductinginnovativedigitalnof1trials
AT zenneralexanderm studyuaplatformfordesigningandconductinginnovativedigitalnof1trials
AT strelownils studyuaplatformfordesigningandconductinginnovativedigitalnof1trials
AT ruetherdariusf studyuaplatformfordesigningandconductinginnovativedigitalnof1trials
AT henschelflorian studyuaplatformfordesigningandconductinginnovativedigitalnof1trials
AT manaswinimanisha studyuaplatformfordesigningandconductinginnovativedigitalnof1trials
AT pottbackerfabian studyuaplatformfordesigningandconductinginnovativedigitalnof1trials
AT edelmanjonathana studyuaplatformfordesigningandconductinginnovativedigitalnof1trials
AT owoyelebabajide studyuaplatformfordesigningandconductinginnovativedigitalnof1trials
AT danielettomatteo studyuaplatformfordesigningandconductinginnovativedigitalnof1trials
AT goldeneddye studyuaplatformfordesigningandconductinginnovativedigitalnof1trials
AT zweigmicol studyuaplatformfordesigningandconductinginnovativedigitalnof1trials
AT nadkarnigirishn studyuaplatformfordesigningandconductinginnovativedigitalnof1trials
AT bottingererwin studyuaplatformfordesigningandconductinginnovativedigitalnof1trials